Ubs Asset Management Americas Inc Theravance Biopharma, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 150,039 shares of TBPH stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,039
Previous 117,505
27.69%
Holding current value
$1.45 Million
Previous $947,000
49.0%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding TBPH
# of Institutions
129Shares Held
46.5MCall Options Held
600Put Options Held
300-
Madison Avenue Partners, LP New York, NY9.51MShares$91.9 Million14.29% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$72 Million2.02% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$46 Million9.1% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$36.5 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$26.7 Million2.79% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $645M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...